• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelia

tetano

Editor, Senior Moderator
Vaccine. 2017 Sep 26. pii: S0264-410X(17)31306-3. doi: 10.1016/j.vaccine.2017.09.058. [Epub ahead of print]
[h=1]Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells.[/h] Forero A[SUP]1[/SUP], Fenstermacher K[SUP]2[/SUP], Wohlgemuth N[SUP]2[/SUP], Nishida A[SUP]1[/SUP], Carter V[SUP]1[/SUP], Smith EA[SUP]1[/SUP], Peng X[SUP]1[/SUP], Hayes M[SUP]2[/SUP], Francis D[SUP]3[/SUP], Treanor J[SUP]3[/SUP], Morrison J[SUP]1[/SUP], Klein SL[SUP]2[/SUP], Lane A[SUP]4[/SUP], Katze MG[SUP]5[/SUP], Pekosz A[SUP]6[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The host innate immune response to influenza virus is a key determinant of pathogenic outcomes and long-term protective immune responses against subsequent exposures. Here, we present a direct contrast of the host responses in primary differentiated human nasal epithelial cell (hNEC) cultures following infection with either a seasonal H3N2 influenza virus (WT) or the antigenically-matched live-attenuated vaccine (LAIV) strain. Comparison of the transcriptional profiles obtained 24 and 36h post-infection showed that the magnitude of gene expression was greater in LAIV infected relative to that observed in WT infected hNEC cultures. Functional enrichment analysis revealed that the antiviral and inflammatory responses were largely driven by type III IFN induction in both WT and LAIV infected cells. However, the enrichment of biological pathways involved in the recruitment of mononuclear leukocytes, antigen-presenting cells, and T lymphocytes was uniquely observed in LAIV infected cells. These observations were reflective of the host innate immune responses observed in individuals acutely infected with influenza viruses. These findings indicate that cell-intrinsic type III IFN-mediated innate immune responses in the nasal epithelium are not only crucial for viral clearance and attenuation, but may also play an important role in the induction of protective immune responses with live-attenuated vaccines.
Copyright ? 2017. Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] Epithelial cells; Host response; Inflammation; Influenza virus; Interferon; Live-attenuated vaccine

PMID: 28967519 DOI: 10.1016/j.vaccine.2017.09.058
 
Back
Top Bottom